BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elmallah MIY, Micheau O. Epigenetic Regulation of TRAIL Signaling: Implication for Cancer Therapy. Cancers (Basel) 2019;11:E850. [PMID: 31248188 DOI: 10.3390/cancers11060850] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Fu X, Li H, Gao Y, Wang W, Shen Y. Leptin differentially regulate cell apoptosis and cycle by histone acetylation in tibial and vertebral epiphyseal plates. Cell Biol Int 2023;47:660-8. [PMID: 36453460 DOI: 10.1002/cbin.11968] [Reference Citation Analysis]
2 Bär SI, Pradhan R, Biersack B, Nitzsche B, Höpfner M, Schobert R. New chimeric HDAC inhibitors for the treatment of colorectal cancer. Arch Pharm (Weinheim) 2023;356:e2200422. [PMID: 36442846 DOI: 10.1002/ardp.202200422] [Reference Citation Analysis]
3 Li Y, Li F, Sun Z, Li J. A review of literature: role of long noncoding RNA TPT1-AS1 in human diseases. Clin Transl Oncol 2023;25:306-15. [PMID: 36112261 DOI: 10.1007/s12094-022-02947-z] [Reference Citation Analysis]
4 Pellegrino M, Ricci E, Ceraldi R, Nigro A, Bonofiglio D, Lanzino M, Morelli C. From HDAC to Voltage-Gated Ion Channels: What's Next? The Long Road of Antiepileptic Drugs Repositioning in Cancer. Cancers (Basel) 2022;14:4401. [PMID: 36139561 DOI: 10.3390/cancers14184401] [Reference Citation Analysis]
5 Dogan B. Machine learning approaches to quantitively predict selectivity of compounds against hDAC1 and hDAC6 isoforms.. [DOI: 10.1101/2022.07.10.499476] [Reference Citation Analysis]
6 Park J, Lee K, Kim K, Yi SJ. The role of histone modifications: from neurodevelopment to neurodiseases. Signal Transduct Target Ther 2022;7:217. [PMID: 35794091 DOI: 10.1038/s41392-022-01078-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Semba M, Takamatsu S, Komazawa-sakon S, Miyoshi E, Nishiyama C, Nakano H, Moriwaki K. Proscillaridin A Sensitizes Human Colon Cancer Cells to TRAIL-Induced Cell Death. IJMS 2022;23:6973. [DOI: 10.3390/ijms23136973] [Reference Citation Analysis]
8 Hu L, Li H, Zi M, Li W, Liu J, Yang Y, Zhou D, Kong QP, Zhang Y, He Y. Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development. Front Cell Dev Biol 2022;10:822816. [PMID: 35252191 DOI: 10.3389/fcell.2022.822816] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
9 Martínez-Iglesias O, Carrera I, Naidoo V, Cacabelos R. AntiGan: An Epinutraceutical Bioproduct with Antitumor Properties in Cultured Cell Lines. Life (Basel) 2022;12:97. [PMID: 35054489 DOI: 10.3390/life12010097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tufano M, Cesaro E, Martinelli R, Pacelli R, Romano S, Romano MF. FKBP51 Affects TNF-Related Apoptosis Inducing Ligand Response in Melanoma. Front Cell Dev Biol 2021;9:718947. [PMID: 34589486 DOI: 10.3389/fcell.2021.718947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Ozyerli-Goknar E, Bagci-Onder T. Epigenetic Deregulation of Apoptosis in Cancers. Cancers (Basel) 2021;13:3210. [PMID: 34199020 DOI: 10.3390/cancers13133210] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
12 Gao L, Wu ZX, Assaraf YG, Chen ZS, Wang L. Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function. Drug Resist Updat 2021;57:100770. [PMID: 34175687 DOI: 10.1016/j.drup.2021.100770] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
13 Dewanjee S, Vallamkondu J, Kalra RS, Chakraborty P, Gangopadhyay M, Sahu R, Medala V, John A, Reddy PH, De Feo V, Kandimalla R. The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus. Cells 2021;10:1340. [PMID: 34071497 DOI: 10.3390/cells10061340] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
14 Vaughan HJ, Zamboni CG, Radant NP, Bhardwaj P, Revai Lechtich E, Hassan LF, Shah K, Green JJ. Poly(beta-amino ester) nanoparticles enable tumor-specific TRAIL secretion and a bystander effect to treat liver cancer. Mol Ther Oncolytics 2021;21:377-88. [PMID: 34189258 DOI: 10.1016/j.omto.2021.04.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Deng L, Zhai X, Liang P, Cui H. Overcoming TRAIL Resistance for Glioblastoma Treatment. Biomolecules 2021;11:572. [PMID: 33919846 DOI: 10.3390/biom11040572] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
16 Singh M, Kumar V, Sehrawat N, Yadav M, Chaudhary M, Upadhyay SK, Kumar S, Sharma V, Kumar S, Dilbaghi N, Sharma AK. Current paradigms in epigenetic anticancer therapeutics and future challenges. Semin Cancer Biol 2021:S1044-579X(21)00063-8. [PMID: 33766649 DOI: 10.1016/j.semcancer.2021.03.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
17 Singh D, Tewari M, Singh S, Narayan G. Revisiting the role of TRAIL/TRAIL-R in cancer biology and therapy. Future Oncol 2021;17:581-96. [PMID: 33401962 DOI: 10.2217/fon-2020-0727] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
18 Luparello C, Mauro M, Arizza V, Vazzana M. Histone Deacetylase Inhibitors from Marine Invertebrates. Biology (Basel) 2020;9:E429. [PMID: 33260710 DOI: 10.3390/biology9120429] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
19 Teng CC, Tung SY, Lee KC, Lee KF, Huang WS, Shen CH, Hsieh MC, Huang CY, Sheen JM, Kuo HC. Novel regulator role of CIL-102 in the epigenetic modification of TNFR1/TRAIL to induce cell apoptosis in human gastric cancer. Food Chem Toxicol 2021;147:111856. [PMID: 33246054 DOI: 10.1016/j.fct.2020.111856] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Gutierrez MJ, Nino G, Hong X, Wang X. Epigenomics and Early Life Human Humoral Immunity: Novel Paradigms and Research Opportunities. Front Immunol 2020;11:1766. [PMID: 32983086 DOI: 10.3389/fimmu.2020.01766] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Deng D, Shah K. TRAIL of Hope Meeting Resistance in Cancer. Trends Cancer 2020;6:989-1001. [PMID: 32718904 DOI: 10.1016/j.trecan.2020.06.006] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 13.0] [Reference Citation Analysis]
22 Elmallah MIY, Cogo S, Constantinescu AA, Elifio-Esposito S, Abdelfattah MS, Micheau O. Marine Actinomycetes-Derived Secondary Metabolites Overcome TRAIL-Resistance via the Intrinsic Pathway through Downregulation of Survivin and XIAP. Cells 2020;9:E1760. [PMID: 32708048 DOI: 10.3390/cells9081760] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
23 Rutz J, Janicova A, Woidacki K, Chun FK, Blaheta RA, Relja B. Curcumin-A Viable Agent for Better Bladder Cancer Treatment. Int J Mol Sci 2020;21:E3761. [PMID: 32466578 DOI: 10.3390/ijms21113761] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
24 Gao H, Lou S, Hong H, Ge Q, Zhao H. Autophagy Inhibition Potentiates the Anticancer Effects of a Bendamustine Derivative NL-101 in Acute T Lymphocytic Leukemia. Biomed Res Int 2020;2020:1520651. [PMID: 32149078 DOI: 10.1155/2020/1520651] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]